A/Michigan/45/2015 Pdm09 + A/Switzerland/8060/2017- Cepa Analoga + B/Colorado/06/2017- Cepa Similar + B/Phuket/3073/2013-Cepa Analoga

—

In supply · Australia

Fluarix Tetra

In supply · 🇦🇺 Australia

In supply in Australia

No active shortage reported.

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

Product attributes reference data we hold

Active ingredient (INN)	A/Michigan/45/2015 Pdm09 + A/Switzerland/8060/2017- Cepa Analoga + B/Colorado/06/2017- Cepa Similar + B/Phuket/3073/2013-Cepa Analoga
Brand names	Fluarix Tetra
Therapeutic category	Auto-created by DIGEMID — Discontinuidad de Medicamentos (Peru) scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.